跳至主要内容
临床试验/ITMCTR2100004357
ITMCTR2100004357招募中1 期

Clinical study on treatment of primary headache with liver-yang hyperactivity syndrome by He-Sea acupoints

The Second Affiliated Hospital of Shandong University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. Patients who meet the diagnostic criteria of Western medicine and traditional Chinese medicine for primary headache;
  • 2. Patients aged 18-70 years old;
  • 3. Male and female are not limited;
  • 4. Patients who have not received all kinds of treatment measures related to the disease in recent one month;
  • 5. The patients who signed the informed consent form voluntarily participated in and obeyed the arrangement of the research group and insisted on completing the treatment.

排除标准

  • 1. Pregnant or lactating women;
  • 2. Patients suffering from diseases of important organs or other diseases that may seriously endanger life;
  • 3. Patients with headache but accompanied by other diseases, such as post-traumatic brain syndrome and brain organic lesions;
  • 4. Patients with acupuncture sickness or allergic constitution.

研究者

发起方
The Second Affiliated Hospital of Shandong University of Chinese Medicine

相似试验